| Working Paper |
File Downloads |
Abstract Views |
| Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
| Between territorial and virtual proximities. The digitization process of the French ecosystem of complementary local currencies |
0 |
0 |
2 |
37 |
2 |
2 |
6 |
70 |
| Capitalisme, pouvoir et organisations: pourquoi le capitalisme est plus qu'une économie de marché |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
23 |
| Changement institutionnel, isomorphisme institutionnel et les relations entre dynamique sectorielle et diversité des modèles productifs |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
37 |
| Construction (sociale) des marchés et régulations environnementales: un point de vue institutionnaliste |
0 |
0 |
0 |
0 |
1 |
1 |
2 |
27 |
| Construction of mental health categories |
0 |
0 |
0 |
3 |
1 |
1 |
2 |
30 |
| Construction politique des marchés et politiques des prix. Le cas de l'industrie pharmaceutique |
0 |
0 |
0 |
0 |
0 |
1 |
3 |
88 |
| Cryptocurrencies and Blockchain: Opportunities and Limits of a New Monetary Regime |
0 |
0 |
0 |
0 |
2 |
3 |
4 |
55 |
| Cryptocurrencies and Blockchain: Opportunities and Limits of a New Monetary Regime |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
39 |
| Cryptocurrencies and Blockchain: Opportunities and Limits of a New Monetary Regime |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
23 |
| De la place de la théorie de la valeur et de la monnaie dans la théorie de la régulation: critique et synthèse |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
19 |
| EU Competition Policy Revisited: Economic Doctrines Within European Political Work |
0 |
0 |
3 |
278 |
3 |
3 |
15 |
349 |
| EU Competition policy revisited: Economic Doctrines within european political work |
0 |
0 |
0 |
0 |
2 |
2 |
4 |
101 |
| Economie institutionnelle et sociologie économique: l'institutionnalisme et la question des frontières disciplinaires |
0 |
0 |
0 |
0 |
2 |
2 |
3 |
13 |
| Finance and Industrial Dynamics (In French) |
0 |
0 |
1 |
53 |
0 |
2 |
4 |
279 |
| Finance et dynamiques des industries |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
13 |
| Financialisation and Industrial Dynamics in the U.S. Pharmaceutical and Defense Industries: an Institutionalist Approach |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
7 |
| Financialisation and industrial dynamics in defense and pharmaceutical industries: an institutionalist approach |
0 |
0 |
0 |
0 |
1 |
2 |
2 |
9 |
| Financialisation and productive models: some theorical proposals on the basis of pharmaceutical industry |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
12 |
| Financialisation of strategies, risk transfer, liquidity, property and control (In French) |
0 |
0 |
0 |
105 |
2 |
3 |
3 |
332 |
| Financialisation, product-policy and variety of capitalism: the case of pharmaceutical sector |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
8 |
| Financialization and productive models in the pharmaceutical industry |
0 |
0 |
1 |
1 |
1 |
2 |
8 |
21 |
| Financiarisation et capitalisme cognitif: interprétation institutionnaliste du cas de l'industrie pharmaceutique |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
19 |
| Financiarisation et dynamiques sectorielles: les cas de l'armement et de la pharmacie depuis la décennie 90 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
9 |
| Financiarisation et dynamiques sectorielles: les cas de l'armement et de la pharmacie depuis la décennie 90 |
0 |
0 |
0 |
0 |
2 |
2 |
4 |
12 |
| Financiarisation et modèles productifs: quelques propositions à partir du cas des industries pharmaceutiques |
0 |
0 |
0 |
0 |
0 |
1 |
3 |
16 |
| Financiarisation et modèles productifs: quelques propositions à partir du cas des industries pharmaceutiques et de la santé |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
25 |
| History, Economics and Society: Dividends of Development, Dividends of Interdisciplinarity An interview with Mary O’Sullivan |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
20 |
| How financialisation shapes productive models in pharmaceutical industry: the domination and contradictions of the blockbuster conception of control (In French) |
0 |
0 |
2 |
66 |
0 |
1 |
6 |
175 |
| How financialisation shapes productive models in pharmaceutical industry: the domination and contradictions of the blockbuster conception of control (In French) |
0 |
0 |
1 |
66 |
2 |
3 |
5 |
214 |
| How financialization shapes productive models in pharmaceutical industry: the domination and contradictions of the blockbuster productive model |
0 |
0 |
0 |
0 |
2 |
2 |
4 |
88 |
| Institutions and the environment: the case for a historical political economy |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
12 |
| Institutions and the environment: the case for a historical political economy |
0 |
0 |
0 |
117 |
0 |
0 |
2 |
218 |
| Institutions and the environment: the case for a historical political economy |
0 |
2 |
5 |
127 |
0 |
2 |
8 |
229 |
| Institutions and the environment: the case for a political socio-economy of environmental conflicts |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
16 |
| L'industrie pharmaceutique face aux mutations Chapitre 5 |
0 |
0 |
0 |
0 |
2 |
2 |
3 |
13 |
| L'influence de la financiarisation sur les modèles d'affaire dans l'industrie pharmaceutique: convergences et contradiction du modèle blockbuster |
0 |
0 |
0 |
0 |
1 |
1 |
2 |
17 |
| L'influence de la financiarisation sur les modèles d'affaire dans l'industrie pharmaceutique: convergences et contradictions du modèle blockbuster |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
18 |
| L'influence de la financiarisation sur les modèles productifs dans l'industrie pharmaceutique: domination et contradictions de la conception du contrôle blockbuster |
0 |
0 |
0 |
0 |
1 |
2 |
3 |
22 |
| La financiarisation des Big Pharma: de l'insoutenable modèle blockbuster à son dépassement ? |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
36 |
| La financiarisation des stratégies: transferts de risque, liquidité, propriété et contrôle |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
23 |
| La financiarisation des stratégies: transferts de risque, liquidité, propriété et contrôle |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
27 |
| La géographie mondiale du capital investissement |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
14 |
| Le développement du Private equity en Europe: diversités géographiques et rôle des configurations institutionnelles |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
11 |
| Logiques financières et dynamique industrielle |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
9 |
| L’économie des plateformes comme nouvelle forme de capitalisme |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
35 |
| L’émergence des nichebusters |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
20 |
| Platform economy as a new form of capitalism. A Régulationist research program |
0 |
0 |
0 |
0 |
2 |
2 |
3 |
84 |
| Platform economy as a new form of capitalism: a Régulationist research programme |
0 |
0 |
0 |
2 |
1 |
1 |
7 |
56 |
| Pouvoir et crise du capital. Marx penseur du XXI° siècle |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
10 |
| Regulating the drugs market in the EU: the contradiction between safety, innovation and access to care |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
23 |
| Sanofi-Aventis and the Complexity of Capitalist Organization |
0 |
0 |
0 |
0 |
1 |
1 |
2 |
26 |
| Shareholder value and social construction of markets: the cases of US defense and pharmaceutical industry |
0 |
0 |
0 |
0 |
2 |
2 |
2 |
7 |
| Shareholder value, political work and globalization in pharmaceutical industry |
0 |
0 |
0 |
0 |
1 |
1 |
3 |
26 |
| Stock market and employment security: The French case |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
13 |
| The Platform economy as a new form of capitalism. A Regulationistresearch program |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
49 |
| The development of Private equity in Europe: the role of institutional configurations |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
11 |
| The development of Private equity in Europe: the role of institutional configurations |
0 |
0 |
0 |
0 |
2 |
2 |
2 |
10 |
| The end of trajectory in pharma. A case study on Aventis, Merck & Co, GSK |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
20 |
| The end of trajectory of pharma. A case study of Aventis |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
16 |
| The political construction of orphan drugs market: between innovation & access to care |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
21 |
| Travail et revenu |
0 |
0 |
0 |
0 |
1 |
1 |
2 |
24 |
| Une analyse de la diversité géographique des opérations de private equity en Europe: le rôle des configurations institutionnelles |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
16 |
| Valeur actionnariale et construction sociale des marchés: les cas des secteurs pharmaceutiques et de la défense américain |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
9 |
| Valeur et monnaie dans la théorie de la régulation. Critique et synthèse |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
16 |
| Vers une socio-économie du développement durable ? L'apport de l'institutionnalisme historique |
0 |
0 |
0 |
0 |
2 |
3 |
3 |
16 |
| Total Working Papers |
0 |
2 |
15 |
855 |
46 |
61 |
142 |
3,306 |